Search

Displaying results 6731 - 6740 of 6949 in total
  1. Drug

    Elsiglutide

    go.drugbank.com/drugs/DB06336
    Investigational

  2. Drug

    SPC2968

    go.drugbank.com/drugs/DB06351
    Investigational

    SPC2968 is a synthetic antisense oligodeoxynucleotide targeting hypoxia-inducible factor-1alpha (HIF-1alpha). It was under investigation in clinical trial NCT02564614 (A Study of Hypoxia-inducible Factor 1a (HIF1A) Messenger Ribonucleic ...

  3. Drug

    Tarazepide

    go.drugbank.com/drugs/DB06435
    Experimental

  4. Drug

    Repinotan

    go.drugbank.com/drugs/DB06506
    Investigational

    Repinotan is a high-affinity, selective, full agonist of the 5HT1A-receptor subtype with neuroprotective properties.

    Categories: Serotonin Receptor Antagonists, Serotonin 5-HT1 Receptor Antagonists
  5. Drug

    Labradimil

    go.drugbank.com/drugs/DB06549
    Investigational

  6. Drug

    Lixivaptan

    go.drugbank.com/drugs/DB06666
    Investigational

  7. Drug

    Inecalcitol

    go.drugbank.com/drugs/DB04796
    Investigational

  8. Drug

    Chromic citrate

    go.drugbank.com/drugs/DB14526
    Experimental

  9. Drug

    SPP 301

    go.drugbank.com/drugs/DB05290
    Investigational

    SPP301 (Avosentan) is a potent and highly selective ET[A] receptor blocker and is clinically investigated in diabetic nephropathy.

  10. Drug

    Custirsen

    go.drugbank.com/drugs/DB05487
    Investigational

    Custirsen acts as a selective estrogen receptor modulator (SERM), inhibiting the proliferation of estrogen-sensitive breast cancer cells. … This agent also inhibits growth and induces apoptosis of glioblastoma cells via a mechanism independent of estrogen receptor-related mechanisms.